Literature DB >> 1282052

Substrate specificity of the Trypanosoma cruzi trans-sialidase.

F Vandekerckhove1, S Schenkman, L Pontes de Carvalho, S Tomlinson, M Kiso, M Yoshida, A Hasegawa, V Nussenzweig.   

Abstract

Trypanosoma cruzi trypomastigotes acquire sialic acid (SA) from host glycoconjugates by means of a plasma membrane-associated trans-sialidase (TS). Here we study the substrate specificity of TS, which differs from all known sialyltransferases in that it does not require cytidine monophosphate (CMP)-SA as donor. The T. cruzi TS reversibly transfers SA to saccharides with terminal beta-Gal (but not alpha-Gal) residues. Donors are saccharides with SA linked to terminal beta-Gal residues by (alpha 2-3), but not (alpha 2-6) bonds. The type of beta-linkage of the terminal Gal residue is of minor importance (beta 1-4 and beta 1-6 are slightly better than beta 1-3), whereas chain length and the structure of additional vicinal sugar residues are not relevant. SA on the surface of living trypomastigotes of T. cruzi is transferred back and forth between the parasite surface and acceptor molecules with terminal beta-Gal, either in solution or on the surface of neighbouring mammalian cells. Addition of fucose residue on or close to the terminal galactose impairs TS activity. As a consequence, the enzyme acts poorly on the E-selectin ligand sialyl-Lewisx and its precursor Lewisx, and in vitro adhesion of TS-treated neutrophils to L-cells expressing L-selectin is not affected. Modifications in the structure of the (alpha 2-3)-linked N-acetyl-neuraminic acid (Neu5Ac) (deoxy or methoxy) of the donor molecules do not impair transfer if the changes are at C9, whereas changes at C4, C7 and C8 impair the ability to donate the modified SA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282052     DOI: 10.1093/glycob/2.6.541

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  22 in total

Review 1.  Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles.

Authors:  Anil K Chava; Sumi Bandyopadhyay; Mitali Chatterjee; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.

Authors:  Ozlem Demir; Adrian E Roitberg
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

3.  Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.

Authors:  Bill R Miller; Adrian E Roitberg
Journal:  J Mol Graph Model       Date:  2013-08-16       Impact factor: 2.518

4.  Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.

Authors:  Isadora A Oliveira; Arlan S Gonçalves; Jorge L Neves; Mark von Itzstein; Adriane R Todeschini
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

5.  Galactosyl-lactose sialylation using Trypanosoma cruzi trans-sialidase as the biocatalyst and bovine κ-casein-derived glycomacropeptide as the donor substrate.

Authors:  Maarten H Wilbrink; Geert A ten Kate; Sander S van Leeuwen; Peter Sanders; Erik Sallomons; Johannes A Hage; Lubbert Dijkhuizen; Johannis P Kamerling
Journal:  Appl Environ Microbiol       Date:  2014-07-25       Impact factor: 4.792

6.  The nematode Caenorhabditis elegans synthesizes unusual O-linked glycans: identification of glucose-substituted mucin-type O-glycans and short chondroitin-like oligosaccharides.

Authors:  Y Guérardel; L Balanzino; E Maes; Y Leroy; B Coddeville; R Oriol; G Strecker
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

7.  Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.

Authors:  Juan Mucci; Alejandra Hidalgo; Esteban Mocetti; Pablo F Argibay; M Susana Leguizamon; Oscar Campetella
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.

Authors:  N M Alcântara-Neves; L C Pontes-de-Carvalho
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

9.  O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi.

Authors:  J O Previato; C Jones; L P Gonçalves; R Wait; L R Travassos; L Mendonça-Previato
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

10.  Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.

Authors:  Leonardo Freire-de-Lima; Frederico Alisson-Silva; Sebastião T Carvalho; Christina M Takiya; Maurício M Rodrigues; George A DosReis; Lucia Mendonça-Previato; José O Previato; Adriane R Todeschini
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.